Positions

Selected Publications

Academic Article

Year Title Altmetric
2022 Autonomic neuropathy as post-acute sequela of SARS-CoV-2 infection: a case reportJournal of NeuroVirology.  28:158-161. 2022
2021 FGF23, a novel muscle biomarker detected in the early stages of ALSScientific Reports.  11. 2021
2021 Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy xray absorptiometry in a prospective studyPLoS One.  16. 2021
2021 Metabolic syndrome and peripheral neuropathyMuscle and Nerve.  63:285-293. 2021
2021 Correction to: Porphyric Neuropathy: Pathophysiology, Diagnosis, and Updated Management (Current Neurology and Neuroscience Reports, (2020), 20, 12, (56), 10.1007/s11910-020-01078-8)Current Neurology and Neuroscience Reports.  21. 2021
2021 Orthostatic intolerance in post-concussion patientsThe Physician and Sportsmedicine2021
2021 Single-institutional reference values for concentric needle jitter analysis using the extrapolated reference values procedure: Comparison to published reference valuesMuscle and Nerve.  63:113-116. 2021
2020 Porphyric Neuropathy: Pathophysiology, Diagnosis, and Updated ManagementCurrent Neurology and Neuroscience Reports.  20. 2020
2020 Wnt antagonist FRZB is a muscle biomarker of denervation atrophy in amyotrophic lateral sclerosisScientific Reports.  10. 2020
2020 Consistent improvement with eculizumab across muscle groups in myasthenia gravisAnnals of Clinical and Translational Neurology.  7:1327-1339. 2020
2020 ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumabJournal of Neurology.  267:1991-2001. 2020
2020 The vitamin D activator CYP27B1 is upregulated in muscle fibers in denervating disease and can track progression in amyotrophic lateral sclerosisThe Journal of Steroid Biochemistry and Molecular Biology.  200. 2020
2020 Hereditary Transthyretin Amyloidosis: Clinical Presentation and Management UpdatesJournal of Clinical Neuromuscular Disease.  21:144-156. 2020
2020 Fibulin-5 mutation featuring Charcot-Marie-Tooth disease, joint hyperlaxity, and scoliosisNeurology Genetics.  6. 2020
2019 Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis (Quality of Life Research, (2019), 28, 8, (2247-2254), 10.1007/s11136-019-02148-2)Quality of Life Research.  28:2255. 2019
2019 Eculizumab improves fatigue in refractory generalized myasthenia gravisQuality of Life Research.  28:2247-2254. 2019
2019 Hereditary Sensory and Autonomic Neuropathies: Adding More to the ClassificationCurrent Neurology and Neuroscience Reports.  19. 2019
2019 Long-term safety and efficacy of eculizumab in generalized myasthenia gravisMuscle and Nerve.  60:14-24. 2019
2019 Congenital myopathy with a novel SELN missense mutation and the challenge to differentiate it from congenital muscular dystrophyJournal of Clinical Neuroscience.  62:238-239. 2019
2019 Plantar Ulcers and Neuropathic Arthropathies: Associated Diseases, Polyneuropathy Correlates, and Risk CovariatesAdvances in Skin and Wound Care: the journal for wound prevention and healing.  32:168-175. 2019
2018 Muscle microRNA signatures as biomarkers of disease progression in amyotrophic lateral sclerosisNeurobiology of Disease.  114:85-94. 2018
2018 Subacute demyelinating polyradiculoneuropathy complicating Epstein–Barr virus infection in GATA2 haploinsufficiencyMuscle and Nerve.  57:150-156. 2018
2017 Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre studyLancet Neurology.  16:976-986. 2017
2017 History of electromyography and nerve conduction studies: A tribute to the founding fathersJournal of Clinical Neuroscience.  43:54-60. 2017
2017 Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosisPLoS One.  12. 2017
2017 Renaut Corpuscles or Peripheral Nerve Infarcts? A Historical OverviewCanadian Journal of Neurological Sciences.  44:184-189. 2017
2016 Electromyographic Findings in Gracilis Muscle Grafts Used to Augment Elbow Flexion in Traumatic Brachial PlexopathyJournal of Clinical Neurophysiology.  33:549-553. 2016
2016 Clinical spectrum of valosin containing protein (VCP)-opathyMuscle and Nerve.  54:94-99. 2016
2016 Clinical and Electrophysiological Findings in Hereditary Inclusion Body Myopathy Compared with Sporadic Inclusion Body MyositisJournal of Clinical Neuromuscular Disease.  17:190-196. 2016
2015 Transforming growth factor beta (TGF-β) is a muscle biomarker of disease progression in ALS and correlates with smad expressionPLoS One.  10. 2015
2015 Charcot Marie Tooth disease (CMT): historical perspectives and evolutionJournal of Neurology.  262:801-805. 2015
2015 Sensory manifestations of diabetic neuropathies: Anatomical and clinical correlationsProsthetics and Orthotics International.  39:7-16. 2015
2014 Smads as muscle biomarkers in amyotrophic lateral sclerosisAnnals of Clinical and Translational Neurology.  1:778-787. 2014
2014 Novel OPA1 mutation featuring spastic paraparesis and intestinal dysmotilityMolecular Genetics and Metabolism Reports.  1:443-445. 2014
2013 Epidemiological features of amyotrophic lateral sclerosis in a large clinic-based African American populationAmyotrophic lateral sclerosis & frontotemporal degeneration.  14:334-337. 2013

Education And Training

  • University of Alabama Birmingham Medical Center Neurology, Residency
  • Mayo Clinic Neurology, Postdoctoral Fellowship
  • Doctor of Medicine, 2001
  • Full Name

  • Mohamed Kazamel